{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:57:48Z","timestamp":1715950668485},"reference-count":68,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T00:00:00Z","timestamp":1319155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Familial hypercholesterolaemia is a disorder of low\u2010density lipoprotein (LDL) cholesterol metabolism, which is associated with the onset of vascular changes associated with coronary heart disease in childhood. This disorder has co\u2010dominant transmission with a prevalence of one in 500 in the general population. Cascade screening is the most effective method of identifying children. Children in the at\u2010risk group should have their cholesterol levels checked between the age of 2 and 10\u2003years. Children with LDL cholesterol levels \u2265 3.4\u2003mmol\/L are likely to suffer from this disorder, although at this level there is a significant false positive rate. Molecular genetic testing is available for the LDL receptor gene, APOB gene and the PCSK9 gene. This is the most specific test for familial hypercholesterolaemia but has a false negative rate of 20\u201350%. Once diagnosed, treatment should be considered in children with an LDL cholesterol level \u2265 4.9\u2003mmol\/L. If the child has two other risk factors or a positive family history, this threshold should be lowered to \u22654.1\u2003mmol\/L. Guidelines recommend that treatment should be commenced by the age of 10\u2003years, although some advise waiting until menarche in females. Statin therapy is currently recommended as first line treatment. Randomised placebo trials have shown that statin therapy reduces LDL cholesterol levels by 25% and is not associated with increased risk of adverse events. These are short\u2010term studies, and longer follow\u2010up will be required to definitively prove efficacy and safety.<\/jats:p>","DOI":"10.1111\/j.1440-1754.2011.02206.x","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T13:13:18Z","timestamp":1319202798000},"update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of familial hypercholesterolaemia in children and adolescents"],"prefix":"10.1111","volume":"48","author":[{"given":"Robert N","family":"Justo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,21]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.992123"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2008.11.006"},{"key":"e_1_2_9_4_2","unstructured":"Australian Bureau of Statistics.Population by age and sex Australian States and Territories.2010. Available from:http:\/\/www.abs.gov.au\/ausstats\/abs@.nfs\/mf\/3201.0[accessed 9 February 2011]."},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000121398"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.183679"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01793.x"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2008.00436.x"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5688(09)71802-1"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.057000"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2008.06.003"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318925"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.07.035"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.02.022"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054013"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.11.016"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1349"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39300.616076.55"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.181946"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.08.004"},{"key":"e_1_2_9_21_2","unstructured":"Familial Hypercholesterolaemia Western Australia Program Committee.Familial hypercholesterolaemia. Office of Population Health Genomics Department of Health Government of Western Australia 2008;1\u201355. Available from:http:\/\/www.genomics.health.wa.gov.au\/fh\/index.cfm[accessed 20 February 2011]."},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2009.tb02304.x"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.105247"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.647891"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2008.135"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.11.015"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.10.004"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181810b30"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.620864"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.07.012"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/gte.2006.10.77"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.12.001"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2010.02.002"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.718981"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115968"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2010.246"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32833ab869"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.184184"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.06.006"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4901.100522"},{"key":"e_1_2_9_41_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima\u2010media thickness task force","volume":"21","author":"Stein JH","year":"2008","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000097034"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2006.05.009"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1328-y"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.07.034"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01746-6"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2010.02260.x"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32833a6e22"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32831b4685"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3557"},{"issue":"1","key":"e_1_2_9_51_2","first-page":"CD001918","article-title":"Dietary treatment for familial hypercholesterolaemia","author":"Shafiq N","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.2.256"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.157024"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.157461"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.671016"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.145151"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-008-9364-3"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.09.030"},{"issue":"7","key":"e_1_2_9_59_2","first-page":"CD006401","article-title":"Statins for children with familial hypercholesterolaemia","author":"Kuoppala J","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.042"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000035247.42888.82"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0582-7"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.717777"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.3.331"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-005-1304-x"},{"key":"e_1_2_9_66_2","first-page":"247","article-title":"Ezetimibe treatment of paediatric patients with hypercholesterolemia","volume":"198","author":"Clauss S","year":"2008","journal-title":"Atherosclerosis"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02593-7"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1095"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.002"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1754.2011.02206.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1754.2011.02206.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T18:13:28Z","timestamp":1697307208000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1754.2011.02206.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,21]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1440-1754.2011.02206.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1754.2011.02206.x","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,21]]},"assertion":[{"value":"2011-10-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}